DavidJInwardsMD
Hematology • Rochester, MNAssociate Professor, Internal Medicine, Mayo Medical School
Dr. Inwards is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1990 - 1991
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1988 - 1990
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1987
Massachusetts General HospitalResidency, Internal Medicine, 1984 - 1986- Mayo Clinic College of MedicineClass of 1984
Certifications & Licensure
MN State Medical License 1988 - 2024
IA State Medical License 1988 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Cladribine in Patients With Mantle Cell Lymphoma Start of enrollment: 1996 Nov 01
- Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma Start of enrollment: 2003 Feb 01
- Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma Start of enrollment: 2004 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy.Aung M Tun, Yucai Wang, Seth Maliske, Ivana Micallef, David J Inwards
Transplantation and Cellular Therapy. 2024-10-01 - 2 citationsAutologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy.Aung M Tun, Yucai Wang, Seth Maliske, Ivana Micallef, David J Inwards
Haematologica. 2024-07-01 - 1 citationsOutcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.Alexandra Rezazadeh, Aniko Szabo, Arushi Khurana, David J Inwards, Matthew A Lunning
Haematologica. 2024-05-01
Journal Articles
- Primary Systemic Amyloidosis in Patients with Waldenström MacroglobulinemiaAngela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
Abstracts/Posters
- Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?David J Inwards, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Treatment and Lifestyle Risk Factors for Cardiovascular Disease Post Lymphoma Diagnosis: A Prospective Study in the Modern Treatment EraDavid J Inwards, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell LymphomaDavid James J Inwards, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
